南京诺唯赞生物科技股份有限公司

Vazyme - Innovation in Enzyme Technology

Founded in 2012 and located in the Nanjing High-tech Zone (stock code: 688105), Nanjing Vazyme Biotech Co., Ltd. is a biotechnology company focusing on the development of technological innovations and products related to enzymes, antigens, antibodies, and other functional proteins and high molecular organic materials. Leveraging its independently established key technology platform, the company has ventured into fields such as life sciences, in vitro diagnostics, and bio-pharmaceuticals. As one of the few companies in China with both upstream technology development capabilities and downstream product manufacturing capabilities, Vazyme aims to create "biochips" and continuously inject new vitality into the biotechnology industry.

Innovation and Talent Pool

Vazyme has always adhered to innovation and breakthroughs, insisting on developing from the source of technology. With its proprietary core technologies, it has built an independently controllable key technology platform that enables rapid, efficient, and large-scale product development. The company currently offers over 600 types of genetically engineered recombinant enzymes and more than 2,500 high-performance antigens and monoclonal antibodies, along with over 2,000 terminal products applicable to scientific research, high-throughput sequencing, in vitro diagnostics, pharmaceutical and vaccine development, and animal quarantine.

A strong R&D capability is supported by a robust talent pool. Vazyme boasts a team of nearly 700 R&D personnel, including experts in molecular biology, enzymology, immunology, bioinformatics, organic chemistry, and materials science. Over 67% of these R&D staff hold master’s degrees or higher.

Mastery of Core Raw Material Technologies and Downstream Industrial Advantages

Since its establishment, Vazyme has always adhered to a business philosophy centered around R&D, continuously upgrading its core technologies and expanding into new business areas. Through years of relentless efforts, Vazyme has achieved significant technical accomplishments in the fields of biology, healthcare, and pharmaceuticals. It has successfully launched various series of biological reagents, including high-throughput sequencing library construction, PCR, qPCR, molecular cloning, reverse transcription, and Bio-assay, as well as POCT diagnostic reagents covering nine categories such as cardiovascular diseases, inflammation, infections, reproductive health, gastric function, respiratory system, and nervous system. Its customer base includes research institutions, high-throughput sequencing service enterprises, molecular diagnostic reagent manufacturers, pharmaceutical companies, CROs, and hospitals.

Staying True to Our Mission and Fulfilling Responsibilities

While expanding its product and technology chains, Vazyme remains committed to its mission of "Technology for Healthier Lives," constantly developing new technologies, providing high-quality products, and professional services to contribute value to customers. Rooted in the principle of putting hardworking individuals first, Vazyme provides a broad development platform to attract outstanding talents from across the country and even the world, driving the overall development and enhancement of China's biotechnology and medical industries. Actively engaging in public health initiatives, Vazyme uses technology to support national biosafety efforts, helping humanity combat major infectious diseases, tumors, and autoimmune disorders!